Tirtha Chakraborty - Feb 6, 2023 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Signature
/s/ Rich Segal, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
Feb 6, 2023
Transactions value $
$0
Form type
4
Date filed
2/8/2023, 03:18 PM
Previous filing
Sep 6, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Award $0 +47.8K +47.76% $0.00 148K Feb 6, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Employee Stock Option (right to buy) Award $0 +95.5K $0.00 95.5K Feb 6, 2023 Common Stock 95.5K $5.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning February 6, 2023, subject to the Reporting Person's continued service as of each such date.
F2 Includes 3,000 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on November 15, 2022.
F3 The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 6, 2023, in each case subject to the Reporting Person's continued service as of each such date.